Label
Description
5-{2-[2-(2-Ethoxy-phenoxy)-ethylamino]-propyl}-2-methoxy-benzenesulfonamide indication Benign Prostatic Hyperplasia
A Knowledge Graph Assertion from IDG
Naftopidil indication Benign Prostatic Hyperplasia
1-(3-Hydroxy-propyl)-5-((R)-2-{2-[2-(2,2,2-trifluoro-ethoxy)-phenoxy]-ethylamino}-propyl)-2,3-dihydro-1H-indole-7-carboxylic acid amide indication Benign Prostatic Hyperplasia
Tadalafil indication Benign Prostatic Hyperplasia
Dutasteride indication Benign Prostatic Hyperplasia
Finasteride indication Benign Prostatic Hyperplasia
[4-(4-Amino-6,7-dimethoxy-quinazolin-2-yl)-piperazin-1-yl]-(tetrahydro-furan-2-yl)-methanone indication Benign Prostatic Hyperplasia
Androstanediol correlated with condition Benign Prostatic Hyperplasia
A Knowledge Graph Assertion from Metabolomics
Doxazosin indication Benign Prostatic Hyperplasia
Alfuzosin indication Benign Prostatic Hyperplasia